Chronic Pain Clinical Trials

Find Chronic Pain Clinical Trials Near You

Brain Mechanisms Supporting Cannabis-induced Pain Relief

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY

Chronic low back pain is a common and disabling condition that affects millions of people in the United States. Many people with chronic low back pain do not get enough relief from current treatments. Cannabis may help reduce pain, but researchers do not fully understand how it affects the brain in people with chronic pain. The purpose of this study is to examine how inhaled cannabis changes brain activity and reduces pain in people with chronic low back pain. Results from this study may help researchers better understand how cannabis works for pain and support the development of improved pain treatments.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Maximum Age: 65
Healthy Volunteers: t
View:

• Between 21-65 years old

• Currently 30 days cannabis free

• Lower back pain for three months or more

• Are not taking opioids

• If female and of a child bearing potential age, are not pregnant or nursing mothers

• Do not have mental or neurological conditions inhibiting sensory/motor functions

• Do not have a lifetime history of dependence on cannabis

• Do not have a lifetime history of DSM-IV schizophrenia, bipolar disorder, panic disorder, or psychosis

• Prior THC-containing cannabis experience within the past two years

• Agrees not to use cannabis outside of the study during participation in the study

• Agrees not to use opioids or barbiturates during participation in the study

• Agrees not to drive a motor vehicle within 4 hours following last use of inhaled cannabis during participation in the study

Locations
United States
California
Center for Functional MRI - W.M.Keck Building
RECRUITING
La Jolla
Contact Information
Primary
Madelynn Meredith, BS
mameredith@health.ucsd.edu
619-431-1850
Backup
Yasmeen Esshaki, MA
yesshaki@health.ucsd.edu
619-786-0375
Time Frame
Start Date: 2021-05-07
Estimated Completion Date: 2027-03-15
Participants
Target number of participants: 100
Treatments
Experimental: Active THC
Participants will be administered 400mg of vaporized cannabis (5.1%) before pain testing and fMRI.
Placebo_comparator: Placebo THC
Participants will be administered 400mg of vaporized cannabis (\<.1%) before pain testing and fMRI.
Sponsors
Leads: University of California, San Diego

This content was sourced from clinicaltrials.gov